Celastrol Modulates Multiple Signaling Pathways to Inhibit Proliferation of Pancreatic Cancer via DDIT3 and ATF3 Up-Regulation and RRM2 and MCM4 Down-Regulation.
Mahmoud YounsMomen M AskouraHisham A AbbasGouda H AttiaAhdab N KhayyatReham M GodaAhmad J AlmalkiEl-Sayed KhafagyWael A H HegazyPublished in: OncoTargets and therapy (2021)
The current study aims to be a starting point to generate a hypothesis on the most significant regulatory genes and for a full dissection of the celastrol possible effects on each single gene to prevent the pancreatic cancer growth.